About Event

The 2nd Process Development for Cell Therapies Summit takes place at a pivotal time in cell therapy development. The industry is on the precipice of commercial boom, with an unprecedented number of candidates poised for clinical development. There has never been a more important time to share insights learned so far, and create consensus through discussing pitfalls and triumphs in process development so far.

Join Fellow Process Development Innovators to:

icon 1

Innovate analytical methods and ditigal platforms to ensure product quality and efficacy with Immatics Biotechnologes and Lyell Immunopharma

icon 2

Convene on regulations and frameworks for best practices to establish industry standards with CytoImmune Therapeutics and Affini-T Therapeutics


icon 3

Examine disruptive technologies to plug gaps in process workflows from digital systems to closed-system automation with Takeda and Triumvira Immunologics

icon 4

Advance allogeneic and iPSC process development, define batches, and contrast sources for scalable ‘off-the-shelf’ therapy with Century Therapeutics and Arovella Therapeutics

icon 5

Optimize formulation, fill & finish and develop cryopreservation protocols to monitor and maintain product quality with Senti Bio and Be Biopharma

Who will you Meet?

MicrosoftTeams-image (7)

What your peers have to say:

Great content and exposure to the latest progress being made in the field.
Director- Potency, Analytical, Cell Based Assay, Center Excellence and Biologics Bioprocess, Merck*

A huge highlight of my year and the key connections I made will allow for fruitful collaborations and sharing of ideas that will be valuable for years to come.
Biomedical Engineer, National Institute of Standards & Technology, NIST*


*From similar Cell Therapy Events